XML 37 R27.htm IDEA: XBRL DOCUMENT v3.19.2
Fair Value of Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2019
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Measurement
The following tables represent the financial instruments measured at fair value on a recurring basis in the financial statements of the Company and the valuation approach applied to each class of financial instruments at June 30, 2019 and December 31, 2018 (in thousands):

 
June 30, 2019
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
75,672

$

$

$
75,672

Commercial paper

2,394


2,394

Asset-backed securities

1,199


1,199

Corporate notes and bonds

1,206


1,206

Total cash and cash equivalents
$
75,672

$
4,799

$

$
80,471

Investments:
 
 
 
 
Certificates of deposit

6,881


6,881

U.S. Treasury securities
21,011



21,011

U.S. Agency securities

4,008


4,008

Commercial paper

6,080


6,080

Corporate notes and bonds

12,369


12,369

Total investments
21,011

29,338


50,349

Total assets measured at fair value
$
96,683

$
34,137

$

$
130,820


 
December 31, 2018
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
38,444

$

$

$
38,444

Commercial paper

1,493


1,493

Total cash and cash equivalents
38,444

1,493


39,937

Investments:
 
 
 
 
Certificates of deposit

10,787


10,787

U.S. Treasury securities
22,120



22,120

U.S. Agency securities

7,980


7,980

Commercial paper

17,025


17,025

Asset-backed securities

11,998


11,998

Corporate notes and bonds

30,308


30,308

Total investments
22,120

78,098


100,218

Total assets measured at fair value
$
60,564

$
79,591

$

$
140,155